Jove
Visualize
Contact Us

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

868
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
868
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

632
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
632
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

393
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
393
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

567
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
567
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

400
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
400
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

1.2K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global variations in omega-3 fatty acid status and omega-6:omega-3 ratios: insights from > 500,000 whole-blood dried blood spot samples.

Lipids in health and disease·2025
Same author

The Use of a Proprietary Near-Infrared Laser to Enhance Wound Healing: A Preliminary Preclinical and Clinical Study.

Aesthetic surgery journal. Open forum·2025
Same author

Overlapping and separable activities of BRA-2 and HIM-17 promote occurrence and regulation of pairing and synapsis during Caenorhabditis elegans meiosis.

Nature communications·2025
Same author

Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants.

Nature microbiology·2024
Same author

<i>Libifem®</i> (<i>Trigonella foenum-graecum</i>) in conjunction with exercise on muscle strength, power, endurance, and body composition in females aged between 25 and 45 years.

Frontiers in sports and active living·2023
Same author

Perspectives on Neuronutrition in Prevention and Treatment of Neurological Disorders.

Nutrients·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Nov 3, 2025

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.7K

Palmitoylethanolamide: A Natural Compound for Health Management.

Paul Clayton1, Mariko Hill2, Nathasha Bogoda2

  • 1Institute of Food, Brain and Behaviour, Beaver House, 23-28 Hythe Bridge Street, Oxford OX1 2EP, UK.

International Journal of Molecular Sciences
|June 2, 2021
PubMed
Summary

Palmitoylethanolamide (PEA) is a dietary supplement with anti-inflammatory and pain-relieving effects. Advanced formulations improve its absorption, making it a valuable option for managing chronic inflammatory conditions and improving overall health.

Keywords:
ALIAmidesbioactive lipidsdietotherapyendocannbinoidsimmunomodulationimmunomodulatorinflammationlipid signalingmolecular mechanismneuroinflammationnutraceuticalspain

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.4K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.7K

Related Experiment Videos

Last Updated: Nov 3, 2025

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.7K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.4K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.7K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Nutrition Science

Background:

  • Chronic inflammatory stress drives degenerative diseases during nutrition transitions.
  • Dietary supplementation offers a strategy to mitigate these health risks.
  • Palmitoylethanolamide (PEA) is an endogenous lipid mediator with broad therapeutic potential.

Purpose of the Study:

  • To review the functionality of Palmitoylethanolamide (PEA).
  • To support the use of PEA as a dietary supplement for lifestyle management.
  • To highlight advancements in PEA delivery systems.

Main Methods:

  • Literature review of studies on Palmitoylethanolamide (PEA).
  • Analysis of PEA's molecular targets and effects on inflammatory mediators.
  • Evaluation of clinical data on PEA's safety and efficacy.

Main Results:

  • PEA exhibits significant anti-inflammatory, analgesic, immunomodulatory, and neuroprotective effects.
  • PEA is well-tolerated with no reported side effects in humans and animals.
  • Advanced delivery systems have successfully addressed PEA's previous oral bioavailability limitations.

Conclusions:

  • Palmitoylethanolamide (PEA) demonstrates multifaceted therapeutic benefits for immunity, brain health, pain, and more.
  • Improved bioavailability enhances PEA's utility as a dietary supplement.
  • PEA is a promising option for lifestyle management of chronic inflammatory conditions.